Flibanserin

Key facts

Active substance
Flibanserin
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/20/2008
PIP number
Flibanserin
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Hypoactive Sexual Desire Disorder in Women
Route(s) of administration
Oral
Contact for public enquiries
Boehringer Ingelheim GmbH
E-mail:
paediatrics@boehringer-ingelheim.com
Country: Germany
Phone: +49 6132778271
Fax: +49 6132776601
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating
Average
1 rating